In addition, a non-invasive method, 18F-FDG PET-CT, has been evaluated comprehensively to predict EGFR mutation status in patients with NSCLC (Lv et al., 2018; Liu et al., 2020; Mu et al., 2020). Here, EGFR is linked to non-small cell lung carcinoma.